A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease

Journal of the American College of Cardiology

Volumn 64, Issue 10, 2014, Pages 959-968

  Karmali, Kunal N ^a   Goff, David C ^b   Ning, Hongyan ^a   Lloyd Jones, Donald M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Global Health and Health Disparities   (United States)

Author keywords

Cardiovascular disease; Primary prevention; Risk assessment; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGE; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; HISPANIC; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; HYPERCHOLESTEROLEMIA; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PREVALENCE; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK FACTORS; SEX RATIO; STANDARD; UNITED STATES;

CARDIOVASCULAR DISEASE; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS;

ADULT; AGE DISTRIBUTION; AGED; AMERICAN HEART ASSOCIATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SMOKING; UNITED STATES;

EID: 84908179151     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1186     Document Type: Article

References (21)

1. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;63:2889-934.
2. Goff DC Jr., Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;63:2935-59.
3. Lackland DT, Elkind MS, D'agostino R Sr., et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:1998-2027.
4. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels In the ATP-III risk assessment tool. Prev Med 2008;47:619-23.
5. Marma AK, Lloyd-Jones DM. Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile. Circulation 2009;120:384-90.
6. The ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
7. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-76.
8. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
9. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham study. Ann N Y Acad Sci 1963;107:539-56.
10. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronaryheart disease in families. The Framingham offspring study. Am J Epidemiol 1979;110:281-90.
11. 2013 Prevention Guidelines ASCVD Risk Estimator. Available at: http://www.cardiosource.org/science-and-quality/practice-guidelines-and-qualitystandards/2013-prevention-guideline-tools.aspx. Accessed April 21, 2014.
12. Wright JD, Hughes JP, Ostchega Y, Yoon SS, Nwankwo T. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008. National Health Statistics Reports 2011:1-22, 24.
13. Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA 2012;308:1545-54.
14. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011;123:1243-62.
15. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:E28-292.
16. Howard VJ, Kleindorfer DO, Judd SE, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol 2011; 69:619-27.
17. Safford MM, Brown TM, Muntner PM, et al. Association of race and sex with risk of incident acute coronary heart disease events. JAMA 2012; 308:1768-74.
18. Howard G, Cushman M, Kissela BM, et al. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke 2011; 42:3369-75.
19. Kittner SJ, White LR, Losonczy KG, Wolf PA, Hebel JR. Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA 1990; 264:1267-70.
20. Kleindorfer D. Sociodemographic groups at risk: race/ethnicity. Stroke 2009;40:S75-8.
21. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009;26:142-8.